tetrahydrocurcumin has been researched along with bilirubin in 1 studies
| Studies (tetrahydrocurcumin) | Trials (tetrahydrocurcumin) | Recent Studies (post-2010) (tetrahydrocurcumin) | Studies (bilirubin) | Trials (bilirubin) | Recent Studies (post-2010) (bilirubin) |
|---|---|---|---|---|---|
| 170 | 4 | 112 | 25,921 | 1,337 | 5,871 |
| Protein | Taxonomy | tetrahydrocurcumin (IC50) | bilirubin (IC50) |
|---|---|---|---|
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 3.3884 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.3183 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murugan, P; Pari, L | 1 |
1 other study(ies) available for tetrahydrocurcumin and bilirubin
| Article | Year |
|---|---|
Protective role of tetrahydrocurcumin against erythromycin estolate-induced hepatotoxicity.
Topics: Administration, Oral; Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Bilirubin; Butylated Hydroxytoluene; Chemical and Drug Induced Liver Injury; Cholesterol; Curcumin; Erythromycin Estolate; Fatty Acids, Nonesterified; Female; Glutathione; Lipid Peroxides; Phospholipids; Rats; Rats, Wistar; Silymarin; Thiobarbiturates; Triglycerides | 2004 |